Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Research On Cocaine-related Renal Disease To Benefit From NIH Stimulus Funding
A Medical College of Georgia nurse researcher is among the first in the nation to receive National Institutes of Health stimulus funding through the American Recovery and Reinvestment Act of 2009.
generic viagra online
New Study Finds Positive Developments, Persistent Problems In Medicare Drug Plan
A new study finds more seniors are covered by a Medicare drug plan and report greater savings, but gaps in coverage and other problems still persist.
News of the day
Families Of Sudden Unexplained Death Victims Should Receive Comprehensive Cardiogenetic Testing
Relatives of a young person who dies suddenly should always be referred for cardiological and genetic examination in order to identify if they too are at risk of sudden death, a scientist told the annual conference of the European Society of Human Genetics. Dr. Christian van der Werf, a research fellow at the Department of Cardiogenetics, Academic Medical Centre, Amsterdam, The Netherlands said that, although his team"s research showed that inherited heart disease was present in over 30% of the families of sudden unexplained death (SUD) victims, the majority of such relatives were currently not being referred for examination.
Mental Health

BioClinica Advances Standards Support At DIA 2009

Bio-Imaging Technologies, Inc., (NASDAQ: BITI) d/b/a BioClinica, a global provider of clinical trial services with more than two decades of experience and a thorough understanding of standards, is challenging the industry to increase standards implementation for clinical trials at the Drug Information Association (DIA) 45th Annual Meeting on June 21-25 in San Diego (booth #315). Standards support has quickly become a key focus for the life science industry to streamline the clinical trial process and reduce costs. However, the complexity of the task and the re requirements put implementing standards on the "someday list" for many companies. "Applicable standards are fully ready for use right now, making it vital that life science companies move forward with implementation," said Mark Weinstein, President and CEO of BioClinica. "Unfortunately, this is often a difficult undertaking, especially when plates are full and budgets are challenged. Nevertheless, implementing clinical data standards will ultimately reduce costs and increase efficiency. We believe partners that understand clinical processes and standards are essential." Standards to support the acquisition, exchange and submission of clinical research data are paramount to increase the affordability and accessibility of medical research and improve the clinical trial process. Life science companies should prioritize incorporation of these standards into their data management practices to gain a competitive advantage, simplify processes and decrease costs during the clinical trial process. Vendor partners can play a vital role to assist their clients to stay ahead of the curve and reap the rewards. "The time has come to use technology more strategically," continued Weinstein. "The clinical research process will become more efficient only when we collectively support the development of standards, as well as their widespread adoption and implementation." BioClinica


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009